PLX - "The Company will provide the drug free of charge to patients enrolled in the protocol."
What are the implications of this decision by the FDA? Its an open label study so obviously progress must be good. Why isn't the share price rocketing up? It seems a forgone conclusion.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.